ResMed Inc (RSMDF) stock
RSMDFOTCSurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RMD
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026Score 21/3011% below fair value
$22.61+0.00 (0.00%)
Close on Oct 19, 2026Market cap $33.17BP/E 22.0Yield 1.04%
ResMed pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
ResMed's pe ratio was 23.0× on Oct 19, 2026, against 26.0× a year earlier. Over the last 5 years it ranged from 18.4× to 76.4×, with a median of 31.3×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 23.0× | −1.7 |
| 2025 | Dec 31, 2025 | 24.7× | −5.6 |
| 2024 | Dec 31, 2024 | 30.3× | +2.4 |
| 2023 | Dec 29, 2023 | 27.9× | −11.0 |
| 2022 | Dec 30, 2022 | 38.9× | −37.5 |
| 2021 | Dec 31, 2021 | 76.4× | +30.8 |
| 2020 | Dec 31, 2020 | 45.6× | −8.0 |
| 2019 | Dec 31, 2019 | 53.6× | +4.5 |
| 2018 | Dec 31, 2018 | 49.1× | +14.8 |
| 2017 | Dec 29, 2017 | 34.3× | +9.0 |
| 2016 | Dec 30, 2016 | 25.3× | +3.6 |
| 2015 | Dec 31, 2015 | 21.7× | −1.4 |
| 2014 | Dec 31, 2014 | 23.2× | +1.5 |
| 2013 | Dec 31, 2013 | 21.7× | −0.5 |
| 2012 | Dec 31, 2012 | 22.2× | +4.2 |
| 2011 | Dec 30, 2011 | 18.0× | −7.7 |
| 2010 | Dec 31, 2010 | 25.7× | −1.8 |
| 2009 | Dec 31, 2009 | 27.5× | – |